Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells-;a type of cancer immunotherapy-;that can be switched on to varying degrees of intensity and then ...

More than 90% of cervical cancer cases are caused by human papillomavirus (HPV) infection. HPV is a common sexually ...

Researchers have developed an in vitro cancer model to investigate why breast cancer spreads to bone. Their findings hold promise for advancing the development of preclinical tools to predict breast ...

Grade 3-5 adverse events were comparable between both treatment groups. Evidence Rating Level: 1 (Excellent) Study Rundown: ...

Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in ...

Notably, 370 (83%) participants had squamous cell carcinoma ... outcomes for individuals with metastatic or recurrent cervical cancer. This evolution provides a pathway towards personalised treatment ...

Some estimates attribute as many as 20 percent of cancer cases to infectious agents, such as Epstein-Barr virus and hepatitis ...

The National University Health System and National University of Singapore CAR T team of Dr Esther Chan (left), Dr Bernice Oh (centre) and Professor Allen Yeoh at the National University Hospital ...

Professor Ahmed Ahmed, study leader and director of the ovarian cancer cell laboratory at MRC Weatherall ... in a larger number of patients with melanoma post-surgery, to ensure it is an effective ...

Oct 2 (Reuters) - Formula One will not hold a sprint race for rookie drivers in Abu Dhabi after the final grand prix of the season, the governing FIA said on Wednesday. The concept has been ...

Crown Castle's (NYSE:CCI) reported talks to sell its fiber business and small cell business for $8 billion to $10 billion is driving shares lower on Wednesday as the price is on the lower side of ...

Furthermore, these cells, called CAR-T cells, appear to be capable of targeting diseased cells in the tumor that do not carry this antigen, while sparing healthy cells. These results, published in the ...